Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

1,564 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Epidermal growth factor receptor tyrosine kinase inhibition up-regulates interleukin-6 in cancer cells and induces subsequent development of interstitial pneumonia.
Ishiguro Y, Ishiguro H, Miyamoto H. Ishiguro Y, et al. Oncotarget. 2013 Apr;4(4):550-9. doi: 10.18632/oncotarget.939. Oncotarget. 2013. PMID: 23592411 Free PMC article.
Alterations of p16 and p14ARF genes and their 9p21 locus in oral squamous cell carcinoma.
Ohta S, Uemura H, Matsui Y, Ishiguro H, Fujinami K, Kondo K, Miyamoto H, Yazawa T, Danenberg K, Danenberg PV, Tohnai I, Kubota Y. Ohta S, et al. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009 Jan;107(1):81-91. doi: 10.1016/j.tripleo.2008.08.027. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009. PMID: 19101490
Clinical benefit of high-sensitivity KRAS mutation testing in metastatic colorectal cancer treated with anti-EGFR antibody therapy.
Kimura T, Okamoto K, Miyamoto H, Kimura M, Kitamura S, Takenaka H, Muguruma N, Okahisa T, Aoyagi E, Kajimoto M, Tsuji Y, Kogawa T, Tsuji A, Takayama T. Kimura T, et al. Oncology. 2012;82(5):298-304. doi: 10.1159/000336792. Epub 2012 Apr 28. Oncology. 2012. PMID: 22555244
Collapsin response mediator protein 4 expression is associated with liver metastasis and poor survival in pancreatic cancer.
Hiroshima Y, Nakamura F, Miyamoto H, Mori R, Taniguchi K, Matsuyama R, Akiyama H, Tanaka K, Ichikawa Y, Kato S, Kobayashi N, Kubota K, Nagashima Y, Goshima Y, Endo I. Hiroshima Y, et al. Ann Surg Oncol. 2013 Dec;20 Suppl 3:S369-78. doi: 10.1245/s10434-012-2491-3. Epub 2012 Jul 18. Ann Surg Oncol. 2013. PMID: 22805864
Androgen deprivation therapy prevents bladder cancer recurrence.
Izumi K, Taguri M, Miyamoto H, Hara Y, Kishida T, Chiba K, Murai T, Hirai K, Suzuki K, Fujinami K, Ueki T, Udagawa K, Kitami K, Moriyama M, Miyoshi Y, Tsuchiya F, Ikeda I, Kobayashi K, Sato M, Morita S, Noguchi K, Uemura H. Izumi K, et al. Oncotarget. 2014 Dec 30;5(24):12665-74. doi: 10.18632/oncotarget.2851. Oncotarget. 2014. PMID: 25557268 Free PMC article.
Epidermal growth factor receptor-targeted molecular imaging of colorectal tumors: Detection and treatment evaluation of tumors in animal models.
Miyamoto Y, Muguruma N, Fujimoto S, Okada Y, Kida Y, Nakamura F, Tanaka K, Nakagawa T, Kitamura S, Okamoto K, Miyamoto H, Sato Y, Takayama T. Miyamoto Y, et al. Cancer Sci. 2019 Jun;110(6):1921-1930. doi: 10.1111/cas.14020. Epub 2019 May 20. Cancer Sci. 2019. PMID: 30973663 Free PMC article.
Poly-(ADP-Ribose) Polymerase-1 Promotes Prothrombin Gene Transcription and Produces Des-Gamma-Carboxy Prothrombin in Hepatocellular Carcinoma.
Taniguchi T, Kishi K, Nakagawa T, Tanaka H, Tanaka T, Tomonari T, Okamoto K, Sogabe M, Miyamoto H, Okahisa T, Muguruma N, Kajimoto M, Sagawa I, Takayama T. Taniguchi T, et al. Digestion. 2017;95(3):242-251. doi: 10.1159/000470837. Epub 2017 Apr 7. Digestion. 2017. PMID: 28384634
EGFR Downregulation after Anti-EGFR Therapy Predicts the Antitumor Effect in Colorectal Cancer.
Okada Y, Kimura T, Nakagawa T, Okamoto K, Fukuya A, Goji T, Fujimoto S, Sogabe M, Miyamoto H, Muguruma N, Tsuji Y, Okahisa T, Takayama T. Okada Y, et al. Mol Cancer Res. 2017 Oct;15(10):1445-1454. doi: 10.1158/1541-7786.MCR-16-0383. Epub 2017 Jul 11. Mol Cancer Res. 2017. PMID: 28698359
Multicenter phase II study of capecitabine plus cisplatin as first-line therapy for human epidermal growth factor receptor 2-negative advanced gastric cancer: Yokohama Clinical Oncology Group Study YCOG1107.
Sato K, Kunisaki C, Kosaka T, Takagawa R, Takahashi M, Izumisawa Y, Miyamoto H, Sato S, Tanaka Y, Yamaguchi N, Kimura J, Ono HA, Makino H, Akiyama H, Endo I. Sato K, et al. Cancer Chemother Pharmacol. 2017 Nov;80(5):939-943. doi: 10.1007/s00280-017-3430-6. Epub 2017 Sep 14. Cancer Chemother Pharmacol. 2017. PMID: 28913549 Clinical Trial.
1,564 results
Jump to page
Feedback